All articles tagged: Neoplasm of unspecified behavior of unspecified site (D49.9)

Patients with neuroglial tumors are ideal epilepsy surgical candidates, with good long-term outcomes observed, according to a study published online May 22 in Frontiers in Neurology.Attila Rácz, M.D., Ph.D., from the University Hospital Bonn in Germany, and colleagues evaluated long-term outcomes and potential influencing factors a

There has been an increase in breast cancer incidence rates among young U.S. women from 2000 to 2019, according to a study published online Jan. 26 in JAMA Network Open.Shuai Xu, M.P.H., from Washington University School of Medicine in St. Louis, and colleagues assessed recent trends and how period and cohort effects may affect tr

For patients with advanced melanoma, early 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging can identify metabolic changes that may predict response to pembrolizumab, according to a study published online Jan. 24 in Clinical Cancer Research.Thomas M. Anderson, M.D., from the Per

For percutaneous lung ablation, high-frequency jet ventilation (HFJV) under general anesthesia seems as safe as spontaneous respiration (SR) under moderate sedation, with longer room time for HFJV, according to a study published online Jan. 24 in the American Journal of Roentgenology.Alexander Graur, from Massachusetts General Hospital

Citing recent indications that CAR T-cell therapy may cause rare secondary cancers, the U.S. Food and Drug Administration has told pharmaceutical companies to add a boxed warning to their products.However, FDA s

The CDC is now recommending doctors to conduct blood testing for "forever chemicals," known as PFAS, to assess exposure and potential health risks. PFAS are persistent chemicals found in various products and environments, raising concerns about their impact on public health.

Men with gynecomastia have a increased risk for all-cause death, especially those with gynecomastia with a known preexisting risk factor, according to a study published online Jan. 16 in BMJ Open.Elvira V. Bräuner, Ph.D., from Copenhagen University Hospital in Denmark, and colleagues conducted a nationwide register-based cohort study in

For patients with immunotherapy recalcitrant KRAS-mutated tumors, the cancer vaccine ELI-002 2P is safe and induces T-cell responses, according to a study published online Jan. 9 in Nature Medicine.Noting that the cancer vaccine ELI-002 2P enhances lymph node delivery and immune response using Amphiphile (Amph)-modification of G12D and

Initiation of immunotherapy for metastatic cancer at the end of life (EOL) is increasing over time, according to a study published online Jan. 4 in JAMA Oncology.Daniel M. Kerekes, M.D., from Yale University in New Haven, Connecticut, and colleagues examined patient characteristics, practice patterns, and risk factors concerning

A risk model comprising six inflammatory-related laboratory parameters can predict outcome in patients with metastatic cancer treated with immune checkpoint inhibitors (ICIs), according to a study published online Dec. 4 in BMC Cancer.Satu Tiainen, from Kuopio University Hospital in Finland, and colleagues obtained laboratory paramete

Across European populations, an artificial intelligence (AI) risk model shows generalizable discriminatory performance for predicting breast cancer among women with a negative mammogram, according to a study published online Dec. 6 in The Lancet Regional Health: Europe.Mikael Eriksson, Ph.D., from the Karolinska Institutet in Stockholm

Hispanic and American Indian or Alaska Native (AI/AN) individuals diagnosed with breast, colorectal, lung, and prostate cancer have been undercaptured in the National Cancer Database (NCDB), but their representation is improving, according to a study published online Dec. 27 in JAMA Network Open.Yasoda Satpathy, from the University o

The annual San Antonio Breast Cancer Symposium was held from Dec. 5 to 9 in San Antonio, with attendees including medical oncologists, radiation oncologists, researchers, and other health care professionals. The conference highlighted recent advances in the risk, diagnosis, treatment, and prevention of breast cancer, and presentations focused on emerging tr

Outdoor air pollution is tied to a higher risk for nonlung cancers in older adults, according to a study published online Aug. 1 in Environmental Epidemiology.Yaguang Wei, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined associations of 10-year exposures to fine particulate matter (PM2.

Among routinely screened women, only a small proportion of advanced breast cancers is attributed to biennial versus annual screening, according to a study published online Dec. 7 in JAMA Oncology.Karla Kerlikowske, M.D., from the University of California in San Francisco, and colleagues examined the population attributable risk proport

For postmenopausal women aged 50 to 69 years with stage 1 hormone receptor-positive breast cancer, the risk for recurrence is very low for those who do not undergo radiotherapy after breast-conserving surgery (BCS), according to a study published online Dec. 7 in the Journal of Clinical Oncology to coincide with the annual San Antonio Breast

The U.S. Food and Drug Administration has approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment.The Fast Track and Breakthrough Therapy-designated approval was based on results from an international, multicenter trial in which 142 adult patients with progressing desmoid tumor

Artificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Oct. 11 to 14 in Berlin.Kashini Andrew, M.B.B.S., from the University Hospitals Birmingham NHS Foundation Trust in the United Kingdom, and colleagues

Among postmenopausal Black women, moderate and heavy use of chemical hair relaxers is associated with an increased risk for uterine cancer, according to a study published online in the upcoming Dec. 15 issue of Environmental Research.Kimberly A. Bertrand, Sc.D., M.P.H., from Slone Epidemiology Center at Boston University, and colleague